Strategies for the Management of Iron Overload in the Transplant SettingRichard J OReillyEmanuele AngelucciMark C Walters
A practical, clinically-oriented handbook of iron overload disorders giving a compact guide to normal iron metabolism, iron-related pathobiology, and the diagnosis and management of heritable and acquired iron overload disorders. Many of these disorders were discovered and characterized only in the las...
Pharmacoeconomic benefits of deferasirox in the management of iron overload syndomes. Expert Rev Pharmaco Outcomes Res 2009;9:297-304.Imran F, Phatak P. Pharmacoeconomic Benefits of Deferasirox in the Management of Iron Overload Syndomes. Expert Rev Pharmacoecon Outcomes Res. 2009;9:297-304....
Domenica Cappellini2 1American University of Beirut, Beirut, Lebanon; 2Universitá di Milano, Policlinico Foundation IRCCS, Milan, Italy Abstract: Regular blood transfusions as supportive care for patients with chronic anemia inevitably lead to iron overload as humans cannot actively remove excess iron...
Introduction: Deferasirox is an oral iron chelator, approved worldwide for the treatment of chronic iron overload due to transfusion. Deferasirox was permitted two years ago in Japan, but there is little known regarding its efficacy and tolerability in clinical practice. Methods: We conducted a ...
Pathogenesis and management of iron toxicity in thalassemia In thalassemia major, iron overload is the joint outcome of multiple blood transfusions and an inappropriately increased iron absorption associated with in... C Hershko - 《Haematologica》 被引量: 335发表: 2010年 Overview on practices in ...
Fesoterodine for the treatment of urinary incontinence and overactive bladder. November 18, 2009 [ MEDLINE Abstract ] Update on the use of deferasirox in the management of iron overload. November 02, 2009 [ MEDLINE Abstract ] Pediatric psoriasis: an update. November 02, 2009 [ MEDLINE...
Iron overload is unlikely in patients with CIA and is discussed for MDS patients. Earlier published studies in patients with gynaecological cancer [89, 90] or with lymphoid malignancies [91] and prospective observational studies [92, 93] have shown that some patients benefit from i.v. iron ...
Thalassaemia disorders predominantly affect individuals of Asian, Mediterranean, Middle Eastern or African descent. Most patients with homozygous 尾-thalas... SUMMARY 被引量: 0发表: 0年 Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related...
Deferiprone,ironoverloadlaboratoryfindings,376 management,438treatment,376,377 Deferoxamine(DFO),ironoverloadrepair,congenitaldefects,308, management,438309 DelayedhemolytictransfusionDownsyndrome,leukemoidreaction reaction(DHTR),featuresandininfancy,130 management,417,418Doxorubicin(Adriamycin®), Dendriticcell(DC...